Sun Pharmaceuticals Industries Ltd logo

SUNPHARMA

Sun Pharmaceuticals Industries Ltd

₹1,527.40

Sun Pharmaceuticals Industries Ltd Q3 FY2023-2024 Results: Summary

Revenue
₹12,630.90Cr
Net Profits
₹2,523.75Cr
Net Profit Margins
19.98%

Highlights

Revenue:

Sun Pharmaceuticals Industries Ltd’s revenue jumped 10.65% since last year same period to ₹12,630.90Cr in the Q3 2023-2024. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 1.16% jump in its revenue since last 3-months.

Net Profits:

Sun Pharmaceuticals Industries Ltd’s net profit jumped 16.52% since last year same period to ₹2,523.75Cr in the Q3 2023-2024. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 6.24% jump in its net profits since last 3-months.

Net Profit Margins:

Sun Pharmaceuticals Industries Ltd’s net profit margin jumped 5.3% since last year same period to 19.98% in the Q3 2023-2024. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 5.02% jump in its net profit margins since last 3-months.

FAQs

The revenue for Sun Pharmaceuticals Industries Ltd in the Q3 results 2023 was ₹12,630.90Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q3 results 2023 was ₹2,523.75Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q3 results 2023 was 19.98%.

The revenue for Sun Pharmaceuticals Industries Ltd in the Q3 results 2022 was ₹11,414.85Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q3 results 2022 was ₹2,166.01Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q3 results 2022 was 18.98%.